Search
Returning search results with filters:
Remove filter for
Audience: Healthcare
Remove filter for
Issue: Health products
Remove filter for
Last updated: 2019
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
- (-) 2019
- December 201913 results available
- November 201910 results available
- October 201920 results available
- September 201919 results available
- August 201914 results available
- July 201914 results available
- June 201914 results available
- May 20198 results available
- April 20199 results available
- March 201914 results available
- February 20197 results available
- January 20193 results available
Recall class
Displaying 121 - 135 of 145 items.
PrBENLYSTA (belimumab) - Increased Risk of Serious Depression, Suicidal Ideation or Behaviour, or Self-Injury
AlertHealth professional risk communication | 2019-04-04
Phenobarb Elixir (2019-03-29)
RecallHealth product recall | 2019-03-29
Neutrarinse 2.0% Caramel (2019-03-26)
RecallHealth product recall | 2019-03-26
Thallous Chloride TI 201 Injection (2019-03-26)
RecallHealth product recall | 2019-03-26
DARZALEX (daratumumab) and Hepatitis B Virus Reactivation
AlertHealth professional risk communication | 2019-03-25
Extraneal (2019-03-22)
RecallHealth product recall | 2019-03-22
Clinique Superdefense Daily Defense Moisturizer SPF 20 (2019-03-14)
RecallHealth product recall | 2019-03-14
TECENTRIQ® (atezolizumab) - Risk of Immune-Related Myositis
AlertHealth professional risk communication | 2019-03-13
Pro Doc Irbesartan Product Recall (2019-03-11)
RecallHealth product recall | 2019-03-11
PMS-Amoxicillin (2019-03-11)
RecallHealth product recall | 2019-03-11
Pharmascience Losartan Product Recall (2019-03-08)
RecallHealth product recall | 2019-03-08
Pro Doc Losartan Product Recall (2019-03-08)
RecallHealth product recall | 2019-03-08
Apotex Losartan Product Recall (2019-03-08)
RecallHealth product recall | 2019-03-08
TEVA-LOSARTAN/HCTZ (2019-03-06)
RecallHealth product recall | 2019-03-06
Phenobarb (2019-03-01)
RecallHealth product recall | 2019-03-01